Hao Xi Ede
Directeur/Membre du Conseil chez DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Fortune : 19 M $ au 30/06/2024
Profil
Actuellement, Hao Xi Ede occupe le poste de directeur financier et directeur exécutif chez Innovent Biologics, Inc. M. Ede siège également au conseil d'administration de Mindray Medical International Ltd. et de Dawnrays Pharmaceutical Holdings Ltd. et est membre de l'Institute of Singapore Chartered Accountants. Dans le passé, M. Ede a été directeur financier chez Viavi Solutions, Inc., directeur financier et secrétaire chez Biosensors International Group Ltd, directeur financier et administrateur chez Mindray Medical International Ltd, directeur général pour l'Asie chez FUJIFILM SonoSite, Inc. et directeur du marketing chez Ernst & Young (Chine). Hao Xi Ede est titulaire d'un diplôme de premier cycle de l'université de Hawai'i à Hilo et d'un MBA de l'université de Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
0,25% | 22/03/2024 | 4 073 616 ( 0,25% ) | 19 M $ | 30/06/2024 |
Postes actifs de Hao Xi Ede
| Sociétés | Poste | Début |
|---|---|---|
| DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED | Directeur/Membre du Conseil | 15/06/2015 |
| INNOVENT BIOLOGICS, INC. | Directeur/Membre du Conseil | 04/06/2018 |
Institute of Singapore Chartered Accountants
 Institute of Singapore Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Institute of Singapore Chartered Accountants provides accounting services. | Corporate Officer/Principal | - |
Anciens postes connus de Hao Xi Ede
| Sociétés | Poste | Fin |
|---|---|---|
| MINDRAY MEDICAL INTERNATIONAL LTD (ADR) | Directeur/Membre du Conseil | 18/05/2023 |
| BIOSENSORS INTERNATIONAL GROUP LTD | Directeur Financier/CFO | 01/01/2016 |
| MINDRAY MEDICAL INTERNATIONAL LTD (ADR) | Directeur Financier/CFO | 01/01/2011 |
| VIAVI SOLUTIONS INC. | Directeur Financier/CFO | 01/01/2008 |
| Ernst & Young (China) | Sales & Marketing | 01/01/2003 |
Formation de Hao Xi Ede
| University of Hawai'i at Hilo | Undergraduate Degree |
| University of Washington | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VIAVI SOLUTIONS INC. | Technology Services |
| DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
FUJIFILM SonoSite, Inc.
 FUJIFILM SonoSite, Inc. Medical SpecialtiesHealth Technology FUJIFILM SonoSite, Inc. engages in the developing, manufacturing and marketing of in hand-carried ultrasound systems, which are used in a variety of medical specialties in a range of clinical settings at the point-of-care. It designs products for applications, including emergency medicine, surgery, critical care, internal medicine, musculoskeletal, and vascular access procedures as well as for imaging in traditional applications, such as radiology, cardiology, vascular medicine and obstetrics and gynecology. The company was founded in April 1998 and is headquartered in Bothell, WA. | Health Technology |
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
Mindray Medical International Ltd.
 Mindray Medical International Ltd. Medical SpecialtiesHealth Technology Mindray Medical International Ltd. is a holding company that engages in the development, manufacture, and distribution of medical devices. Its products include orthopedic and endoscopic devices and healthcare information technology solutions. The company operates through the following segments: Patient Monitoring and Life Support, In-vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Supports Products segments includes patient monitoring devices which tracks the physiological parameters of patients such as heart rate, blood pressure, respiration and temperature for adult, pediatric, and neonatal patients for hospital intensive care units, operating rooms, and emergency rooms; and the life support products are to provide operation room or intensive care unit solutions for the end-users in the operating room. Its products include single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring devices for patient monitoring devices, and anesthesia machines, defibrillators, surgical beds, surgical lights ceiling pendants, syringes, and infusion pumps, and ventilators for the life supports products. The In-vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples. It offers hematology, biochemistry, urine sediment, microbiology, and coagulation analyzers, and reagents. The Medical Imaging Systems segment includes ultrasound, digital radiography, and magnetic resonance imaging systems. The company was founded by Xu Hang and Li Xi Ting on June 10, 2005 and is headquartered in Shenzhen, China. | Health Technology |
| Ernst & Young (China) | |
Institute of Singapore Chartered Accountants
Institute of Singapore Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Institute of Singapore Chartered Accountants provides accounting services. | Commercial Services |
